M
About

Meg Krench joined Sanofi Ventures in 2021 with a background in biotech investing and business development. Previously, she worked as part of the External Innovation team at Vertex Pharmaceuticals and at RA Capital, a crossover investment fund. Meg currently serves as a director for Normunity and as an observer for several companies including Draig Therapeutics, Eligo Bioscience, Korsana Biosciences, Quralis, and a stealth immunology company. Meg also supported Sanofi Ventures’ investment in Aliada Therapeutics before its acquisition by Abbvie for $1.4 billion. Meg holds a Ph.D. in Neuroscience from Massachusetts Institute of Technology and a B.S. with Honors in Neuroscience from The Pennsylvania State University. She is also co-chair of the Board of Directors for the New England Venture Network.

Focus Areas

BioTech

Location

📍 Based in Cambridge

Verified Contact & Outreach Agent

Direct Professional Email Pattern

[email protected] | [email protected]

AI Outreach Agent Pitch Writer

Compose an personalized, high-converting outreach message targeting their exact investment interest...

Unlock Direct Partner Outreach

View verified contact information and use our active Outreach Composer agent to draft custom intro pitches in seconds.

Connect via GRID to Outreach

100% free account · Get started in 1-click